NeoImmuneTech, Inc. (NIT) is a clinical-stage T cell-focused biopharmaceutical company dedicated to expanding the horizon of immuno-oncology and enhancing immunity to infectious diseases.
Our lead drug candidate, NT-I7, is the only clinical-stage long acting rhIL-7, and is uniquely positioned to address unmet medical needs in Immuno-Oncology and Infectious Diseases. IL-7 is a fundamental cytokine for lymphocyte development, survival, and memory development. Furthermore, NT-I7 has been shown clinically to have desired PK/PD and safety profiles, making it an ideal combination partner with T-cell targeted therapies.
NT-I7 is being studied in multiple clinical trials and many in collaboration with industry leaders in I-O, including Merck and Roche for CPI combination trials.
Follow us on X @neoimmunetech
Company Details
- Employees
- 40
- Founded
- -
- Address
- 2400 Research Blvd.,
- Phone
- +82-31-709-5858
- in****@****ech.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- neoimmunetech.com
- HQ
- Rockville, MD
Neoimmunetech Questions
Neoimmunetech's helpline number is +82-31-709-5858
Neoimmunetech's website is neoimmunetech.com
Neoimmunetech's LinkedIn profile is https://www.linkedin.com/company/neoimmunetech
Neoimmunetech has
40 employees.
View email and phone details for 40
employees at Neoimmunetech.
Neoimmunetech's industry is
Biotechnology Research
Neoimmunetech's top competitors are
Immunomic Therapeutics, Inc.,
Immorna,
Macrogenics, Inc.,
Imugene Limited,
Parexel,
Genexine, Inc.,
Vital Gxp Consulting,
Epivax, Inc.,
Elevar Therapeutics,
Psomagen.
Neoimmunetech's support email address is info@neoimmunetech.com
Neoimmunetech's categories are Biotechnology Research
Neoimmunetech's founding year is 2014
